0 results available. Select is focused ,type to refine list, press Down to open the menu,
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product is ZORYVE, a topical roflumilast cream fo...
The following section summarizes insights on Arcutis Biotherapeutics Inc's Net Debt / Total Capital:
We've identified the following companies as similar to Arcutis Biotherapeutics Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Net Debt / Total Capital in the risk category include:
A ratio that measures the level of the net debt relative to the market value of total capital. Net debt is the sum of all long term debt fields minus ...
The chart above depicts the distribution of net debt / total capital for companies operating in the Healthcare sector in the Developed economic region. Over 2,370 companies were considered in this analysis, and 2,280 had meaningful values. The average net debt / total capital of companies in the sector is -12.9% with a standard deviation of 50.5%.
Arcutis Biotherapeutics Inc's Net Debt / Total Capital of -6.4% ranks in the 46.5% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,374 |
| Included Constituents | 2,280 |
| Min | -226.6% |
| Max | 88.5% |
| Median | -3.7% |
| Mean | -12.9% |
| Standard Deviation | 50.5% |
You can find companies with similar net debt / total capital using this stock screener.